CNC - Centene Corporation
NYSE
->
Healthcare
->
Healthcare Plans
St. Louis,
United States
Type: Equity
CNC price evolution
CNC
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17193 | $18190 | $17170 | $15853 |
| Short term investments | $2459 | $2241 | $2212 | $2135 |
| Net receivables | $15532 | $15503 | $13601 | $15210 |
| Inventory | ||||
| Total current assets | $32725 | $41405 | $34866 | $35009 |
| Long term investments | $16286 | $15234 | $16108 | $15833 |
| Property, plant & equipment | $2019 | $2004 | $2416 | $2478 |
| Goodwill & intangible assets | $23659 | $23835 | $25236 | $25566 |
| Total noncurrent assets | $43885 | $42976 | $47987 | $47973 |
| Total investments | $18745 | $17475 | $18320 | $17968 |
| Total assets | $84641 | $84381 | $82853 | $82982 |
| Current liabilities | ||||
| Accounts payable | $16420 | $15081 | $9868 | $10781 |
| Deferred revenue | $715 | $2356 | $2373 | $2398 |
| Short long term debt | $119 | $113 | $110 | $97 |
| Total current liabilities | $36716 | $36851 | $31306 | $32857 |
| Long term debt | $17710 | $17888 | $17896 | $18223 |
| Total noncurrent liabilities | $21969 | $22114 | $25760 | $24939 |
| Total debt | $17829 | $18001 | $18006 | $18320 |
| Total liabilities | $58801 | $58965 | $57066 | $57796 |
| Shareholders' equity | ||||
| Retained earnings | $12043 | $11998 | $11529 | $10471 |
| Other shareholder equity | -$652 | -$1122 | -$998 | -$915 |
| Total shareholder equity | $25840 | $25295 | $25671 | $25042 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17193 | $12074 | $13118 | $10800 |
| Short term investments | $2459 | $2321 | $1539 | $1580 |
| Net receivables | $15532 | $13272 | $12238 | $9696 |
| Inventory | ||||
| Total current assets | $32725 | $30128 | $28497 | $23393 |
| Long term investments | $16286 | $14684 | $14043 | $12853 |
| Property, plant & equipment | $2019 | $2432 | $3391 | $2774 |
| Goodwill & intangible assets | $23659 | $25723 | $27595 | $27040 |
| Total noncurrent assets | $43885 | $46742 | $49878 | $45326 |
| Total investments | $18745 | $17005 | $15582 | $14433 |
| Total assets | $84641 | $76870 | $78375 | $68719 |
| Current liabilities | ||||
| Accounts payable | $16420 | $9525 | $8493 | $7069 |
| Deferred revenue | $715 | $478 | $434 | $523 |
| Short long term debt | $119 | $82 | $267 | $97 |
| Total current liabilities | $36716 | $1716 | $25765 | $21585 |
| Long term debt | $17710 | $17938 | $18571 | $16682 |
| Total noncurrent liabilities | $21969 | $24169 | $25588 | $21172 |
| Total debt | $17829 | $18020 | $18838 | $16779 |
| Total liabilities | $58801 | $52813 | $51353 | $42757 |
| Shareholders' equity | ||||
| Retained earnings | $12043 | $9341 | $8139 | $6792 |
| Other shareholder equity | -$652 | -$1132 | $77 | $337 |
| Total shareholder equity | $25840 | $24057 | $26795 | $25773 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $39460 | $38042 | $37608 | $38889 |
| Cost of revenue | $33491 | $33078 | $34315 | |
| Gross Profit | $3660 | $4551 | $4530 | $4574 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $3048 | $3016 | $3011 | |
| Total operating expenses | $3803 | $3816 | $3359 | $3356 |
| Operating income | $735 | $1171 | $1218 | |
| Income from continuing operations | ||||
| EBIT | $943 | $1599 | $1571 | |
| Income tax expense | -$15 | $293 | $360 | $261 |
| Interest expense | -$183 | $181 | $181 | $180 |
| Net income | ||||
| Net income | $45 | $469 | $1058 | $1130 |
| Income (for common shares) | $469 | $1058 | $1130 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $153999 | $144547 | $125982 | $111115 |
| Cost of revenue | $127891 | $111783 | $95899 | |
| Gross Profit | $17315 | $16656 | $14199 | $15216 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $11589 | $10166 | $9867 | |
| Total operating expenses | $13856 | $15338 | $12415 | $12134 |
| Operating income | $1318 | $1784 | $3082 | |
| Income from continuing operations | ||||
| EBIT | $2627 | $2489 | $3515 | |
| Income tax expense | $899 | $760 | $477 | $979 |
| Interest expense | -$725 | $665 | $665 | $728 |
| Net income | ||||
| Net income | $2702 | $1202 | $1347 | $1808 |
| Income (for common shares) | $1202 | $1347 | $1808 | |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $469 | $1058 | $1130 | |
| Operating activities | ||||
| Depreciation | $328 | $304 | $346 | |
| Business acquisitions & disposals | $21 | $226 | $443 | |
| Stock-based compensation | $50 | $56 | $61 | |
| Total cash flows from operations | $1021 | $2546 | $4269 | |
| Investing activities | ||||
| Capital expenditures | -$136 | -$215 | -$225 | |
| Investments | $550 | -$435 | -$471 | |
| Total cash flows from investing | -$1191 | $435 | -$424 | -$253 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$763 | -$384 | -$423 | |
| Net borrowings | $241 | -$328 | $287 | |
| Total cash flows from financing | -$1658 | -$524 | -$750 | -$183 |
| Effect of exchange rate | -$32 | $26 | -$9 | $2 |
| Change in cash and equivalents | $5122 | $958 | $1363 | $3835 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1202 | $1347 | $1808 | |
| Operating activities | ||||
| Depreciation | $1553 | $1476 | $1259 | |
| Business acquisitions & disposals | $1017 | -$466 | -$3583 | |
| Stock-based compensation | $234 | $203 | $281 | |
| Total cash flows from operations | $6261 | $4205 | $5503 | |
| Investing activities | ||||
| Capital expenditures | -$1004 | -$910 | -$869 | |
| Investments | -$2934 | -$1942 | -$2481 | |
| Total cash flows from investing | -$1191 | -$2921 | -$3299 | -$6955 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3026 | -$297 | -$626 | |
| Net borrowings | -$1144 | $1604 | $839 | |
| Total cash flows from financing | -$1658 | -$4197 | $1362 | $260 |
| Effect of exchange rate | -$32 | -$11 | -$11 | $18 |
| Change in cash and equivalents | $5122 | -$868 | $2257 | -$1174 |
News
Fundamentals
| Market cap | $38.48B |
|---|---|
| Enterprise value | $39.12B |
| Shares outstanding | 534.48M |
| Revenue | $154.00B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $2.70B |
| Revenue Q/Q | 10.96% |
| Revenue Y/Y | 6.54% |
| P/E ratio | 14.24 |
|---|---|
| EV/Sales | 0.25 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.25 |
| P/B ratio | 1.45 |
| Book/Share | 49.57 |
| Cash/Share | 32.17 |
| EPS | $5.06 |
|---|---|
| ROA | 3.23% |
| ROE | 10.61% |
| Debt/Equity | 2.28 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.89 |
| Quick ratio | 0.89 |